Combination of BET and FGFR inhibition as a rational therapeutic strategy for invasive lobular breast cancer

被引：0
|
作者：
O'Connor, Darran P. [1 ]
Walsh, Louise [1 ]
Haley, Kathryn [1 ]
Moran, Bruce
Mooney, Brian [1 ,2 ]
Madden, Stephen [1 ]
Das, Sudipto [1 ]
Rueda, Oscar [3 ]
Dowling, Catriona [1 ]
Vareslija, Damir [1 ]
Chin, Suet-Feung [3 ]
Linn, Sabine [4 ]
Young, Leonie [1 ]
Jirstrom, Karin [5 ]
Crown, John P. [6 ]
Bernards, Rene [4 ]
Caldas, Carlos
Gallagher, William M. [2 ]
Chonghaile, Triona Ni [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin, Ireland
[2] Univ Coll Dublin, Dublin, Ireland
[3] Univ Cambridge, Cambridge, England
[4] Netherlands Canc Inst, Amsterdam, Netherlands
[5] Lund Univ, Malmo, Sweden
[6] St Vincents Univ Hosp, Dublin, Ireland
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-10-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-06
引用
收藏
页数：2
相关论文
共 50 条
  • [31] BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
    Zhang, Zhenfeng
    Ma, Pengfei
    Jing, Ying
    Yan, Ying
    Cai, Mei-Chun
    Zhang, Meiying
    Zhang, Shengzhe
    Peng, Huixin
    Ji, Zhi-Liang
    Di, Wen
    Gu, Zhenyu
    Gao, Wei-Qiang
    Zhuang, Guanglei
    THERANOSTICS, 2016, 6 (02): : 219 - 230
  • [32] Preoperative breast MRI in patients with invasive lobular breast cancer
    Schelfout, K
    Van Goethem, M
    Kersschot, E
    Verslegers, I
    Biltjes, I
    Leyman, P
    Colpaert, C
    Thienpont, L
    Van den Haute, J
    Gillardin, JP
    Tjalma, W
    Buytaert, P
    De Schepper, A
    EUROPEAN RADIOLOGY, 2004, 14 (07) : 1209 - 1216
  • [33] Preoperative breast MRI in patients with invasive lobular breast cancer
    K. Schelfout
    M. Van Goethem
    E. Kersschot
    I. Verslegers
    I. Biltjes
    P. Leyman
    C. Colpaert
    L. Thienpont
    J. Van den Haute
    J. P. Gillardin
    W. Tjalma
    Ph. Buytaert
    A. De Schepper
    European Radiology, 2004, 14 : 1209 - 1216
  • [34] Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast
    Altundag, Kadri
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 779 - 779
  • [35] Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast
    Kadri Altundag
    Annals of Surgical Oncology, 2021, 28 : 779 - 779
  • [36] Rac1 inhibition as a therapeutic strategy in breast cancer
    Senderoff, Dana
    Azzi, Georges
    Goka, Erik
    Lippman, Marc
    CANCER RESEARCH, 2016, 76
  • [37] Combination therapeutic strategy with type I PRMT inhibition in cancer treatment
    Shi, Hui
    Fu, Xingnian
    Liu, Yilin
    Ouyang, Qiugeng
    Wang, Meng
    Huang, Jiaxin
    Wang, Long
    Wang, Youzhen
    Mi, Yuan
    Wu, Haiping
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Another Breast Cancer Entity Confirmed: Genomics of Invasive Lobular Breast Cancer
    Gatza, Michael L.
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1838 - +
  • [39] Invasive lobular carcinoma predicts micrometastasis in breast cancer
    Gainer, Sarah M.
    Lodhi, Ashutosh K.
    Bhattacharyya, Anirban
    Krishnamurthy, Savitri
    Kuerer, Henry M.
    Lucci, Anthony
    JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : 93 - 96
  • [40] Invasive Lobular Breast Cancer: Does Grade Matter?
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2011, 169 (01) : 16 - 18
12345